Correct—the subject we're discussing is the transition to warfarin when stopping therapy on one of the new oral anticoagulants. (The transition from warfarin to one of the new anticoagulants does not present any particular problems.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”